Pith. sign in

REVIEW 4 major objections 5 minor 147 references

Bayesian ACCESS for Understanding Latent Epidemic Trajectories from Publicly Released Suppressed Data: Application to U.S. Opioid-related Overdose Mortality

T0 review · 4 major / 5 minor · reviewed 2026-08-11 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read Bayesian ACCESS recovers latent opioid mortality trajectories from suppressed CDC WONDER counts.

desk verdict A useful integrated framework, but the abstract overclaims subgroup-specific change points, and the lack of simulation means the accuracy claim is unproven. read the letter →

arxiv 2608.09103 v1 pith:LTVLZ27C submitted 2026-08-10 stat.ME stat.AP

Jiahao Cao , Kehe Zhang , Cici Bauer This is my paper · ORCID
classification stat.MEstat.AP MSC 62F1562M1062P10
keywords latentepidemictrajectorieschange-pointdetectioncounttimeseriesdatasuppressionBayesianhierarchicalmodelopioidoverdosemortalityCDCWONDERmixtureoffinitemixtures
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

Opioid-related overdose mortality in the U.S. is usually studied from CDC WONDER counts that suppress any state-race-year cell with 1–9 deaths, which hides exactly the small populations that often carry the highest burden. This paper argues that those suppressed series still contain enough information to infer the latent epidemic trajectory and its structural breaks, provided the suppression rule is put inside the statistical model rather than treated as a missing-data nuisance. The proposed Bayesian ACCESS model does this with a suppression-aware count likelihood, an identity-link autoregressive rate equation with piecewise-constant coefficients, and a clustering prior that lets states share information while keeping group-specific dynamics. Fitted to 1999–2024 data, the model finds a late-period break consistent with the recent national overdose-death decline and reveals distinct trajectories by race, including a much larger innovation component for Black populations. A sympathetic reader should take the paper's central claim to be that publicly released suppressed statistics can support valid subgroup-level epidemic inference, not merely count recovery.

What carries the argument

The load-bearing object is the identity-link autoregressive rate equation $$\lambda_{ikt} = \eta_k\alpha_{it} + \zeta_k\beta_{it}\lambda_{ik(t-1)},$$ adapted from integer-valued GARCH count models to multivariate suppressed series. The innovation $\alpha_{it}$ and persistence $\beta_{it}$ are assumed constant within each temporal segment for each cluster of states, so $\beta<1$ gives geometric settling toward a plateau, $\beta=1$ gives linear growth, and $\beta>1$ gives exponential growth; the model then infers both the number and location of the segments. A mixture-of-finite-mixtures prior on the unknown partition of states, together with a truncated-Poisson prior on the number of change points per cluster and a uniform prior over admissible break locations, lets the model learn the clustering and break structure rather than fixing them. A collapsed Gibbs sampler for cluster assignments and adaptive Metropolis updates for continuous parameters, with parallel tempering, make the multimodal posterior tractable. The machinery's defining move is that the known suppression set $S$ enters the observation model directly, so a suppressed cell is not an imputation target but a constraint on the latent count.

What would settle it

Compare the model's posterior intervals for selected state-race trajectories against restricted-use unsuppressed death counts; if the intervals systematically miss the true counts, or if the observed 2025 and 2026 national rates fall outside the model's predictive intervals once released, the central claim fails.

Watch

Extended reading notes

Core claim

On its own terms, the paper's discovery is that the latent mortality rate for state $i$, race $k$, and year $t$ can be written as $\lambda_{ikt} = \eta_k \alpha_{it} + \zeta_k \beta_{it} \lambda_{ik(t-1)}$, with $\alpha_{it}$ and $\beta_{it}$ piecewise constant within unknown segments that are shared by clustered states, and $\eta_k,\zeta_k$ race-specific multipliers. Conditioning the observed counts on the known suppression set $S=\{1,\ldots,9\}$ turns every suppressed cell into a likelihood term that sums over the possible hidden counts, so uncertainty from suppression flows directly into the posterior distributions of the latent rates and change points. The paper demonstrates the claim by showing that population-weighted posterior national rates track directly observed national rates closely, by reporting state-specific posterior change-point probabilities (strong evidence around 2018 in California, Texas, and Massachusetts; around 2015 in Missouri and Tennessee), and by estimating racial multipliers such as $\eta_{\text{Black}} \approx 3.43$ for the innovation component. It also reports posterior-predictive declines from 2024 to 2026 of roughly 30–40 percent across racial groups, with wide state variation. If the central claim is right, the posterior change-point probabilities are reliable summaries of when the epidemic's regime changed, including the 2023–2024 decline.

Load-bearing premise

The model's identification rests on the assumption that each race-state latent rate follows a first-order autoregression whose coefficients are constant within a few abrupt segments shared by all states in a cluster; if the true dynamics include longer memory, dependence on past observed counts, or smooth rather than abrupt regime changes, the estimated break years and trajectories are not guaranteed to recover the truth.

Editorial extensions

If this is right

  • Posterior change-point probabilities computed from suppressed state-race counts can be treated as evidence about when the epidemic's dynamics changed, so public CDC WONDER files can support structural-break surveillance without restricted-use data.
  • Population-weighted aggregation of the posterior state-level rates reproduces the directly observed national rates, meaning national monitoring can be built from subgroup-level suppressed series rather than relying on unsuppressed national tabulations.
  • The model's predictive distributions place 2026 rates roughly 30–40 percent below 2024 levels for all racial groups, with West Virginia and Kentucky among the largest predicted declines and Iowa and Wyoming among the smallest; these are testable forecasts.
  • The estimated racial multipliers imply distinct dynamics: Black populations have a much larger innovation component, while Asian/Pacific Islander populations have lower innovation and weaker autoregressive persistence, so a single national trend curve misrepresents the epidemic.
  • Because the observation model is generic to count suppression, the same framework can be applied to other suppressed public-health count systems, such as cancer incidence, infectious-disease surveillance, and maternal health.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • If the first-order autoregressive assumption holds, the posterior change-point probability at the end of a series can be read as an early-warning signal: a spike near the final observed year flags a regime shift before it is confirmed by later data. The paper does not propose this surveillance use, but its forecasting recursion makes it a direct extension.
  • The large Black innovation multiplier suggests that year-to-year changes in Black overdose mortality are driven mostly by new shocks rather than persistence of the previous year's rate; an untested implication is that forecasting for this group should weight leading indicators of new drug-market shocks more heavily than extrapolated trends.
  • Because the model clusters states by temporal dynamics rather than geography, the estimated clusters may correspond to policy or drug-supply regimes rather than Census regions; this could be checked by comparing cluster membership against state-level policy timing and fentanyl-seizure data.
  • Treating suppression as a known support constraint rather than an imputation problem may transfer to other disclosure mechanisms, such as noise-infused or differentially private counts, as long as the released value's relationship to the latent count is known; a testable adaptation would replace the suppression likelihood with the appropriate privacy mechanism.
Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

4 major / 5 minor

Summary. The paper proposes Bayesian ACCESS, a hierarchical Bayesian model for latent mortality-rate trajectories and change points from count time series subject to small-cell suppression, and applies it to U.S. state-level opioid-related overdose mortality counts from CDC WONDER, 1999–2024. The model uses an identity-link first-order autoregressive specification for the latent rate, with piecewise-constant cluster-specific AR parameters, multiplicative demographic effects, a mixture-of-finite-mixtures prior on state clustering, and a suppression-aware observation model. The application reports posterior trajectories, change-point probabilities, racial-group multiplier estimates, and 2025–2026 predictions, together with national-level aggregation checks.

Significance. If validated, the methodological contribution would be useful: directly modeling the suppression mechanism rather than imputing suppressed cells, jointly inferring change points and clustering, and propagating suppression uncertainty into latent-rate estimates are sensible and practically important goals for public-health surveillance. The paper is also strong in assembling a plausible hierarchical model in NIMBLE, applying it to a highly policy-relevant dataset, and reporting posterior uncertainty throughout. However, the central claims that the method 'accurately captures' latent trajectories and that the analysis identifies 'subgroup-specific structural changes' are not supported by the current evidence: the model has no race-specific change-point parameters, the national fit is an in-sample diagnostic on data used for hyperparameter calibration, and the 2025–2026 predictions are deterministic recursions of fitted AR parameters. These issues are fixable through rewording and additional validation, but they are load-bearing for the paper's stated contributions.

major comments (4)
  1. [Abstract; §3.2–§3.3; §4] The abstract's claim of 'distinct subgroup-specific epidemic trajectories and structural changes' is not supported by the model structure. In Eq. (3), λ_ikt = η_k α_it + ζ_k β_it λ_ik(t−1), the demographic multipliers η_k and ζ_k are constant over time, while the change points and segment-specific parameters α_it and β_it are shared across all racial groups within a state or cluster. Consequently, the model cannot estimate race-specific change-point timing; the posterior change-point probability p_i(t|D) defined in §3.6 is a state-level quantity, and Figures 3–4 report only state- or national-level probabilities. Section 5 lists higher-order lags and cross-demographic lags as future work but does not acknowledge that the current model's structural changes are demographic-group-invariant. The abstract and Section 4 wording should be revised to say the model captures subgroup-specific rate levels and trends, not subgroup-specific structural changes.
  2. [§3.6; §4; §5] The predictive and validation claims are not backed by out-of-sample evidence. The 2025–2026 predictions are computed by recursively applying the fitted AR parameters as λ_ik(T+h) = α_ikT + β_ikT λ_ik(T+h−1), assuming no additional change point after T; they are therefore in-sample projections of the fitted model rather than independent forecasts. The national-level agreement in Figure 4 compares the population-weighted posterior fit to directly observed national rates from the same CDC WONDER data used to set the hyperparameters in §3.5; this is a fit diagnostic, not a validation of latent-trajectory recovery. Since Section 5 states that 'extensive numerical studies' demonstrate accuracy, those studies should be reported in the main text, or the claims should be explicitly limited to description of the fitted model. A simulation study with known latent trajectories and suppression would be needed to support the statement that Bayesian ACCESS 'accurately captures' latent trajectories and change points.
  3. [§3.5; §4] The hyperparameters are calibrated using 'empirical scale information from the CDC WONDER opioid-related overdose mortality data' (e.g., σ_α = 10^-5, (a_λ, b_λ) = (−10, 2), and the tight prior (μ_η, σ_η) = (0, 0.1)). Because the same data are then used for model comparison (WAIC) and for the national fit assessment, the reported fit statistics may be optimistically biased, and the posterior change-point probabilities may be sensitive to this data-informed prior specification. The paper should report a sensitivity analysis over plausible hyperparameter ranges, or at least discuss the potential circularity of using the same data for prior calibration and model fit evaluation.
  4. [§3.4.2; §3.5] The change-point prior truncates L(g) at L_max = 4 and imposes d_min = 2 for T = 26 years. This restricts each series to at most five segments and at most one change point per two-year interval. For the opioid epidemic, which has multiple waves, this may be reasonable, but the paper does not assess sensitivity to L_max and d_min, and the posterior probabilities in Figure 3 could change materially if the prior allowed more change points or shorter segments. A brief sensitivity check would strengthen the claim that the detected change-point patterns are data-driven rather than artifacts of the truncation bounds.
minor comments (5)
  1. [§5] The opening paragraph of Section 5 in the provided full text runs words together ('Inthisarticle, weintroducedbayesianACCESS'); please correct the typographical spacing.
  2. [Figure 3; §3.6] The lower panel of Figure 3 shows state-level posterior change-point probabilities. Because the model assigns the same change-point configuration to all racial groups within a state, the figure labels should state explicitly that the displayed probabilities are state-level and shared across racial groups, to avoid misleading readers into interpreting them as race-specific.
  3. [§3.2] The identifiability constraint η_1 = ζ_1 = 1 is introduced in Eq. (3) and Section 3.4.4. It would be helpful to state clearly that the reference-group choice changes the interpretation of η_k and ζ_k and that the posterior distributions of these multipliers are relative to the White group.
  4. [§4] The WAIC comparison (28,130.4 vs. 402,220.2) is reported without the effective number of parameters or Monte Carlo standard errors. Adding this information would help readers judge whether the negative binomial model's advantage is well resolved.
  5. [§2; §4] The paper uses 'unreliable' counts (those between 10 and 19) as observed data. Since these counts are flagged by CDC WONDER as unreliable, a brief discussion of how this unreliability is handled in the observation model (or a sensitivity check treating them as censored) would be useful.

Circularity Check

0 steps flagged · score 0.0 of 10

No significant circularity: the Bayesian ACCESS derivation is self-contained; forecasts and model checks are standard uses of the fitted model, and self-citations are not load-bearing.

full rationale

Bayesian ACCESS is a standard Bayesian hierarchical autoregressive change-point model for suppressed counts. The central derivation is self-contained: Eq. (3) defines the latent rate as an AR(1) recursion, and Section 3.6's posterior predictive forecasts λ_ik(T+h) = α_ikT + β_ikT λ_ik(T+h−1) are genuine extrapolations beyond the estimation window, not re-statements of the fitted data. The national-level comparison in Figure 4 is explicitly an in-sample model-fit and aggregation check using the same vital statistics; it is not called an independent prediction, so it does not fit the 'fitted input called prediction' pattern. The hyperparameters in Section 3.5 are weakly data-informed (e.g., σ_α = 10^−5 aligned to national rate scale), but they are spread-out priors and do not force the posterior to equal the prior means. Self-citations (Bauer et al. 2024; Erdman et al. 2021) are used for background and for setting Gmax/Lmax, not as load-bearing justifications of the inference. One interpretive overclaim exists: the Abstract says 'subgroup-specific ... structural changes,' while Section 3.3 shares change points across demographic groups within a state and only state-level change-point probabilities are reported (Section 3.6, Figures 3–4); this is a correctness and interpretation limitation, not a circular derivation, so it does not raise the circularity score.

Assumptions & free parameters 9 free parameters · 7 assumptions · 0 invented entities

The core model rests on a parametric AR(1) latent process, a negative binomial observation model, and a cluster-shared change-point structure. The hyperparameters that make the application run are hand-set and partly informed by the same data, which adds to the circularity burden. No external entities are posited.

free parameters (9)
  • σ_α (Half-Cauchy scale on innovation α) = 1e-5
    Set in Section 3.5 to align with observed national-level mortality rates; a small value shrinks innovations toward zero and is calibrated to the same data being analyzed.
  • (μ_β, σ_β) (lognormal prior on AR coefficient β) = (0, 0.5)
    Centers β near 1 with moderate variability; chosen as weakly informative, Section 3.5.
  • (a_λ, b_λ) (lognormal prior on initial rates) = (-10, 2)
    Prior median on the order of 1e-5, reflecting lower national mortality rates in the early 2000s; data-informed, Section 3.5.
  • (μ_η, σ_η) (prior on innovation multipliers) = (0, 0.1)
    Tight prior around 1 'to provide additional anchoring under weak identifiability,' Section 3.5.
  • (μ_ζ, σ_ζ) (prior on AR multipliers) = (0, 2)
    Weakly informative allowing heterogeneity across racial groups, Section 3.5.
  • σ_φ (prior scale for overdispersion) = 2
    Allows flexible variability in overdispersion, Section 3.5.
  • G_max, L_max (truncation bounds) = 10, 4
    Upper bounds on number of clusters and change points based on prior studies, Section 3.5.
  • λ_L, d_min (change-point prior rate and min spacing) = 1, 2
    Poisson rate and minimum distance between change points, Section 3.5.
  • γ, λ_G (MFM prior parameters) = 1, 4
    Default specification for mixture-of-finite-mixtures, Section 3.5.
assumptions (7)
  • domain assumption Observed counts follow a negative binomial distribution with mean n_ikt λ_ikt and common overdispersion φ; suppression set S = {1,...,9} is the only observation mechanism, and counts 10-19 flagged unreliable are treated as exact.
    Sections 3.1-3.2 and Section 2; if the unreliable flag implies additional measurement error, the likelihood is misspecified.
  • domain assumption Latent rate follows first-order identity-link AR process λ_ikt = η_k α_it + ζ_k β_it λ_ik(t−1).
    Section 3.2, Eq (3); higher-order and cross-demographic lags are deferred to future work in Section 5.
  • domain assumption AR parameters are piecewise constant within clusters; all states in a cluster share the same change points and segment-specific parameters.
    Section 3.3; strong homogeneity assumption within clusters; if false, state-specific changes are masked.
  • ad hoc to paper Multiplicative demographic effects with η_1 = ζ_1 = 1 fix identifiability.
    Section 3.4.4; standard identifying constraint specific to this parameterization.
  • ad hoc to paper Weakly data-informed hyperparameters are fixed using the scale of the same CDC WONDER data.
    Section 3.5; using the analysis data to set priors weakens external validation.
  • domain assumption MCMC convergence is assumed; no diagnostics (R-hat, ESS) are reported.
    Sections 3.6 and 4; chain lengths and burn-in are given but convergence is not demonstrated.
  • domain assumption Forecasts assume no additional change point occurs after T=2024.
    Section 3.6 recursion for λ_ik(T+h); if a new change point occurs, forecasts are invalid.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Bayesian ACCESS for Understanding Latent Epidemic Trajectories from Publicly Released Suppressed Data: Application to U.S. Opioid-related Overdose Mortality." pith.science (2026). https://pith.science/paper/LTVLZ27C

@misc{pith2026260809103,
  author       = {Pith},
  title        = {Pith review of: Bayesian ACCESS for Understanding Latent Epidemic Trajectories from Publicly Released Suppressed Data: Application to U.S. Opioid-related Overdose Mortality},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/LTVLZ27C}},
  note         = {Machine review of arXiv:2608.09103}
}
read the original abstract

Publicly released health statistics play a central role in characterizing temporal trends and identifying structural changes in population health. However, disclosure limitation through suppression of small cell counts, as implemented in systems such as the Centers for Disease Control and Prevention Wide-ranging ONline Data for Epidemiologic Research (CDC WONDER), produces partially observed count data that complicate statistical inference. These challenges are particularly acute for rare outcomes and subgroup analyses, where suppression is widespread and varies across geographic regions, demographic populations, and time. We propose Bayesian ACCESS (Autoregressive Change-point and Clustering Estimation for Suppressed Count Series), a Bayesian hierarchical framework for inference on latent epidemic trajectories and their structural changes from disclosure-limited health statistics. The proposed model directly represents suppressed count data through a suppression-aware observation model, jointly infers multiple temporal change points and latent trajectories, and borrows information across related geographic and demographic populations through Bayesian nonparametric clustering while preserving meaningful heterogeneity. We apply Bayesian ACCESS to opioid-related overdose mortality data from CDC WONDER for U.S. states from 1999 to 2024. The analysis identifies distinct subgroup-specific epidemic trajectories and structural changes that would be difficult to characterize using publicly released health statistics without explicitly accounting for data suppression.

Figures

Figures reproduced from arXiv: 2608.09103 by the authors.

Figure 1
Figure 1. Temporal trends of state-level observed OOD rate (per 100,000 population) and [PITH_FULL_IMAGE:figures/full_fig_p009_1.png] view at source ↗
Figure 2
Figure 2. Illustration of the proposed Bayesian Autoregressive Change-point and Clustering [PITH_FULL_IMAGE:figures/full_fig_p017_2.png] view at source ↗
Figure 3
Figure 3. Posterior summaries of opioid-related overdose mortality rates for six selected [PITH_FULL_IMAGE:figures/full_fig_p022_3.png] view at source ↗
Figures from the paper (2 more)
Figure 4
Figure 4. Figure 4: National opioid-related overdose mortality rates by race. Dots denote observed [PITH_FULL_IMAGE:figures/full_fig_p024_4.png]
Figure 5
Figure 5. Figure 5: State-level race-aggregated opioid-related overdose mortality rates and predicted [PITH_FULL_IMAGE:figures/full_fig_p025_5.png]

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

147 extracted references · 67 canonical work pages

  1. [1]

    Shane and Ekwueme, Donatus U

    Kao, Szu-Yu Zoe and Tutwiler, M. Shane and Ekwueme, Donatus U. and Truman, Benedict I. , year =. Better Data for Decision-Making through. PLOS ONE , volume =

  2. [2]

    Tiwari, Chetan and Beyer, Kirsten and Rushton, Gerard , year =. The. American Journal of Public Health , volume =

  3. [3]

    Estimating county-level mortality rates using highly censored data from CDC WONDER , volume =

    Harrison Quick , doi =. Estimating county-level mortality rates using highly censored data from CDC WONDER , volume =. Preventing Chronic Disease , pmid =

  4. [4]

    Preventing chronic disease , volume=

    Estimating county-level mortality rates using highly censored data from CDC WONDER , author=. Preventing chronic disease , volume=

  5. [5]

    Lawson and Rachel Carroll and Christel Faes and Russell S

    Andrew B. Lawson and Rachel Carroll and Christel Faes and Russell S. Kirby and Mehreteab Aregay and Kevin Watjou , doi =. Spatiotemporal multivariate mixture models for Bayesian model selection in disease mapping , volume =. Environmetrics , keywords =

  6. [6]

    Lawson and Russell S

    Rachel Carroll and Andrew B. Lawson and Russell S. Kirby and Christel Faes and Mehreteab Aregay and Kevin Watjou , doi =. Space-time variation of respiratory cancers in South Carolina: a flexible multivariate mixture modeling approach to risk estimation , volume =. Annals of Epidemiology , keywords =

  7. [7]

    2023 , note =

    NCDAS , title =. 2023 , note =

    2023

  8. [8]

    Mbabazi Kariisa and Nicole L Davis and Sagar Kumar and Puja Seth and Christine L Mattson and Farnaz Chowdhury and ; Christopher and M Jones , keywords =. Morbidity and Mortality Weekly Report Vital Signs: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics-25 States and the District of Columbia, 2019-2020 , url =

    2019

Show all 147 references
  1. [9]

    Friedman and Helena Hansen , doi =

    Joseph R. Friedman and Helena Hansen , doi =. Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic , volume =. JAMA Psychiatry , month =

  2. [10]

    Drug Overdose Deaths in the United States, 2001–2021.NCHS Data Brief, no 457

    Merianne Spencer and Arialdi Miniño and Margaret Warner , city =. Drug Overdose Deaths in the United States, 2001–2021.NCHS Data Brief, no 457. Hyattsville, MD: National Center for Health Statistics. , url =. doi:10.15620/cdc:122556 , institution =

    2001 doi

  3. [11]

    2023 , note =

    CDC , title =. 2023 , note =

    2023

  4. [12]

    Larochelle and Svetla Slavova and Elisabeth D

    Marc R. Larochelle and Svetla Slavova and Elisabeth D. Root and Daniel J. Feaster and Patrick J. Ward and Sabrina C. Selk and Charles Knott and Jennifer Villani and Jeffrey H. Samet , doi =. Disparities in Opioid Overdose Death Trends by Race/Ethnicity, 2018–2019, From the HEA...

    2018

  5. [13]

    JAGS, NIMBLE, Stan: a detailed comparison among Bayesian MCMC software , url =

    Mario Beraha and Daniele Falco and Alessandra Guglielmi , isbn =. JAGS, NIMBLE, Stan: a detailed comparison among Bayesian MCMC software , url =

  6. [14]

    Holan and Christopher K

    Harrison Quick and Scott H. Holan and Christopher K. Wikle , doi =. Zeros and ones: a case for suppressing zeros in sensitive count data with an application to stroke mortality , volume =. Stat , keywords =

  7. [15]

    Holan and Daniell Toth and Marco A.R

    Scott H. Holan and Daniell Toth and Marco A.R. Ferreira and Alan F. Karr , doi =. Bayesian multiscale multiple imputation with implications for data confidentiality , volume =. Journal of the American Statistical Association , keywords =

  8. [16]

    by A Gelman and JB Carlin and HS Stern and DB Rubin Chapman and Jerry R Nedelman , title =

  9. [17]

    Richard McElreath , isbn =

  10. [18]

    Brilleman and Laura D

    Samuel L. Brilleman and Laura D. Howe and Rory Wolfe and Kate Tilling , doi =. Bayesian Piecewise Linear Mixed Models With a Random Change Point , volume =. Epidemiology , month =

  11. [19]

    Andrew Gelman and Jennifer Hill: Data analysis using regression and multilevel/hierarchical models , volume =

    Walter Krämer , doi =. Andrew Gelman and Jennifer Hill: Data analysis using regression and multilevel/hierarchical models , volume =. Statistical Papers , month =

  12. [20]

    Bayesian aggregation of average data: An application in drug development , volume =

    Sebastian Weber and Andrew Gelman and Daniel Lee and Michael Betancourt and Aki Vehtari and Amy Racine-Poon , doi =. Bayesian aggregation of average data: An application in drug development , volume =. The Annals of Applied Statistics , month =

  13. [21]

    RUBIN , doi =

    DONALD B. RUBIN , doi =. Inference and missing data , volume =. Biometrika , pages =

  14. [22]

    Little , issue =

    Roderick JA. Little , issue =. Statistical Analysis of Masked Data. , volume =. Journal of official statistics , pages =

  15. [23]

    Wide-ranging Online Data for Epidemiologic Research

    Centers for Disease Control and Prevention. Wide-ranging Online Data for Epidemiologic Research. , year =

  16. [24]

    Drug Overdose Deaths Among Non-Hispanic Black Men in the U.S.: Age-Specific Projections Through 2025 , volume =

    Rebecca Arden Harris , doi =. Drug Overdose Deaths Among Non-Hispanic Black Men in the U.S.: Age-Specific Projections Through 2025 , volume =. AJPM Focus , keywords =

    2025

  17. [25]

    Kleinman , doi =

    Robert A. Kleinman , doi =. Overdose Deaths Among Non-Hispanic American Indian and Alaska Native Individuals in the US: 1999–2020 , volume =. Journal of General Internal Medicine , month =

    1999

  18. [26]

    Bunting and Staci A

    David Kline and Amanda M. Bunting and Staci A. Hepler and Ariadne Rivera-Aguirre and Noa Krawczyk and Magdalena Cerda , title =. American Journal of Public Health , pages =. 2023 , DOI =

    2023

  19. [27]

    Erdman and Leonard D

    Elizabeth A. Erdman and Leonard D. Young and Dana L. Bernson and Cici Bauer and Kenneth Chui and Thomas J. Stopka , doi =. A Novel Imputation Approach for Sharing Protected Public Health Data , volume =. American Journal of Public Health , month =

  20. [28]

    Fridley and Philip Dixon , doi =

    Brooke L. Fridley and Philip Dixon , doi =. Data augmentation for a Bayesian spatial model involving censored observations , volume =. Environmetrics , keywords =

  21. [29]

    Brillinger , doi =

    David R. Brillinger , doi =. A Biometrics Invited Paper with Discussion: The Natural Variability of Vital Rates and Associated Statistics , volume =. Biometrics , month =

  22. [30]

    Neutral noninformative and informative conjugate beta and gamma prior distributions , volume =

    Jouni Kerman , doi =. Neutral noninformative and informative conjugate beta and gamma prior distributions , volume =. Electronic Journal of Statistics , keywords =

  23. [31]

    Hassan and Ric Bayly and Jack Cordes and Dana Bernson and Cedric Woods and Xiaona Li and Wenjun Li and Leland K

    Cici Bauer and Ghada H. Hassan and Ric Bayly and Jack Cordes and Dana Bernson and Cedric Woods and Xiaona Li and Wenjun Li and Leland K. Ackerson and Marc R. Larochelle and Thomas J. Stopka , doi =. Trends in Fatal Opioid-Related Overdose in American Indian and Alaska Native C...

    1999

  24. [32]

    A comparison of zero-inflated and hurdle models for modeling zero-inflated count data , volume =

    Cindy Xin Feng , doi =. A comparison of zero-inflated and hurdle models for modeling zero-inflated count data , volume =. Journal of Statistical Distributions and Applications , keywords =

  25. [33]

    Zero to k Inflated Poisson Regression Models with Applications , volume =

    Hadi Saboori and Mahdi Doostparast , doi =. Zero to k Inflated Poisson Regression Models with Applications , volume =. Journal of Statistical Theory and Applications , keywords =

  26. [34]

    On estimation of the Poisson parameter in zero-modified Poisson models , volume =

    Ekkehart Dietz and Dankmar B\". On estimation of the Poisson parameter in zero-modified Poisson models , volume =. doi:10.1016/S0167-9473(99)00111-5 , journal =

    doi

  27. [35]

    Yu , doi =

    Hwa Kyung Lim and Wai Keung Li and Philip L.H. Yu , doi =. Zero-inflated Poisson regression mixture model , volume =. Computational Statistics and Data Analysis , keywords =

  28. [36]

    A lack-of-fit test for parametric zero-inflated Poisson models , volume =

    Chin Shang Li , doi =. A lack-of-fit test for parametric zero-inflated Poisson models , volume =. Journal of Statistical Computation and Simulation , keywords =

  29. [37]

    Zero-inflated poisson regression, with an application to defects in manufacturing , volume =

    Diane Lambert , doi =. Zero-inflated poisson regression, with an application to defects in manufacturing , volume =. Technometrics , keywords =

  30. [38]

    Dean and Erin R

    Charmaine B. Dean and Erin R. Lundy , doi =. Overdispersion , year =. Wiley StatsRef: Statistics Reference Online , month =

  31. [39]

    Some remarks on overdispersion , volume =

    D R Cox , issue =. Some remarks on overdispersion , volume =. Biometrika , keywords =

  32. [40]

    C. B. Dean , doi =. Testing for overdispersion in poisson and binomial regression models , volume =. Journal of the American Statistical Association , keywords =

  33. [41]

    Payne and James W

    Elizabeth H. Payne and James W. Hardin and Leonard E. Egede and Viswanathan Ramakrishnan and Anbesaw Selassie and Mulugeta Gebregziabher , doi =. Approaches for dealing with various sources of overdispersion in modeling count data: Scale adjustment versus modeling , volume =. ...

  34. [42]

    A shared component model for detecting joint and selective clustering of two diseases , year =

    Leonhard Knorr-Held and Nicola G Best , doi =. A shared component model for detecting joint and selective clustering of two diseases , year =. Journal of the Royal Statistical Society Series A: Statistics in Society , pages =

  35. [43]

    Bayesian modelling of inseparable space-time variation in disease risk , volume =

    Leonhard Knorr-Held , doi =. Bayesian modelling of inseparable space-time variation in disease risk , volume =. STATISTICS IN MEDICINE , pages =

  36. [44]

    2024 , url =

    R: A Language and Environment for Statistical Computing , author =. 2024 , url =

    2024

  37. [45]

    2024 , version =

    Perry. 2024 , version =. doi:10.5281/zenodo.1211190 , urldate =

    2024 doi

  38. [46]

    Big data and predictive modelling for the opioid crisis: existing research and future potential , volume =

    Chrianna Bharat and Matthew Hickman and Sebastiano Barbieri and Louisa Degenhardt , doi =. Big data and predictive modelling for the opioid crisis: existing research and future potential , volume =. The Lancet Digital Health , month =

  39. [47]

    Development and validation of a risk-score model for opioid overdose using a national claims database , volume =

    Kyu-Nam Heo and Ju-yeun Lee and Young-Mi Ah , doi =. Development and validation of a risk-score model for opioid overdose using a national claims database , volume =. Scientific Reports , month =

  40. [48]

    Developing a novel prediction model in opioid overdose using machine learning; a pilot analytical study , volume =

    Ehsan Sakhaee and Ali Amirahmadi and Morteza Mahdiani and Maziar Shojaei and Hossein Hassanian‐Moghaddam and Roman Bauer and Nasim Zamani and Hossein Pakdaman and Kourosh Gharagozli , doi =. Developing a novel prediction model in opioid overdose using machine learning; a pilot...

  41. [49]

    Centers for Disease Control: Overdose prevention , title =

  42. [50]

    2024 , urldate =

    Drug Overdose Death Rates , url =. 2024 , urldate =

    2024

  43. [51]

    Miniño , city =

    Spencer Merianne Rose and Matthew Garnett and Arialdi M. Miniño , city =. Urban–Rural Differences in Drug Overdose Death Rates, 2020 , url =. 2022 , urldate =

    2020

  44. [52]

    Shover , doi =

    Joseph Friedman and Chelsea L. Shover , doi =. Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010–2021 , volume =. Addiction , month =

    2010

  45. [53]

    A. Y. Walley and Z. Xuan and H. H. Hackman and E. Quinn and M. Doe-Simkins and A. Sorensen-Alawad and S. Ruiz and A. Ozonoff , doi =. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analys...

  46. [54]

    SPATIOTEMPORAL MODELING OF OPIOID ABUSE AND DEPENDENCE OUTCOMES USING BAYESIAN HIERARCHICAL METHODS , school=

    Natalie Sumetsky , keywords =. SPATIOTEMPORAL MODELING OF OPIOID ABUSE AND DEPENDENCE OUTCOMES USING BAYESIAN HIERARCHICAL METHODS , school=

  47. [55]

    Daunter and Steven R

    Lubna Ayoubi and Jessica Pruente and Alecia K. Daunter and Steven R. Erickson and Daniel Whibley and Daniel G. Whitney , doi =. Opioid prescription patterns among commercially insured children with and without cerebral palsy , volume =. Journal of Pediatric Rehabilitation Medi...

  48. [56]

    Applied Missing Data Analysis by Craig K Enders , volume =

    Sally Galbraith , doi =. Applied Missing Data Analysis by Craig K Enders , volume =. Australian & New Zealand Journal of Statistics , month =

  49. [57]

    Donohue and Eric G

    Wei-Hsuan Lo-Ciganic and Julie M. Donohue and Eric G. Hulsey and Susan Barnes and Yuan Li and Courtney C. Kuza and Qingnan Yang and Jeanine Buchanich and James L. Huang and Christina Mair and Debbie L. Wilson and Walid F. Gellad , doi =. Integrating human services and criminal...

  50. [58]

    <b>mice</b> : Multivariate Imputation by Chained Equations in <i>R</i> , volume =

    Stef van Buuren and Karin Groothuis-Oudshoorn , doi =. <b>mice</b> : Multivariate Imputation by Chained Equations in <i>R</i> , volume =. Journal of Statistical Software , keywords =

  51. [59]

    The importance of distribution-choice in modeling substance use data: a comparison of negative binomial, beta binomial, and zero-inflated distributions , volume =

    Brandie Wagner and Paula Riggs and Susan Mikulich-Gilbertson , doi =. The importance of distribution-choice in modeling substance use data: a comparison of negative binomial, beta binomial, and zero-inflated distributions , volume =. The American Journal of Drug and Alcohol Ab...

  52. [60]

    Allen and Allison O’Rourke and Jessica

    Sean T. Allen and Allison O’Rourke and Jessica. A. Johnson and Chelsi Cheatom and Ying Zhang and Brandon Delise and Kellie Watkins and Kathleen Reich and Rick Reich and Cassius Lockett , doi =. Evaluating the impact of naloxone dispensation at public health vending machines in...

  53. [61]

    Courtwright and Catherine S

    Andrew Kolodny and David T. Courtwright and Catherine S. Hwang and Peter Kreiner and John L. Eadie and Thomas W. Clark and G. Caleb Alexander , doi =. The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction , volume =. Annual Review of P...

  54. [62]

    Rudd and Puja Seth and Felicita David and Lawrence Scholl , doi =

    Rose A. Rudd and Puja Seth and Felicita David and Lawrence Scholl , doi =. Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015 , volume =. MMWR. Morbidity and Mortality Weekly Report , pages =

    2010

  55. [63]

    Statistical Learning with Sparsity , url =

    Trevor Hastie and Robert Tibshirani and Martin Wainwright , doi =. Statistical Learning with Sparsity , url =

  56. [64]

    Mattson and Lauren J

    Christine L. Mattson and Lauren J. Tanz and Kelly Quinn and Mbabazi Kariisa and Priyam Patel and Nicole L. Davis , doi =. Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths — United States, 2013–2019 , volume =. MMWR. Morbidity and Mortality Weekly Rep...

    2013

  57. [65]

    Roderick J. A.. Little and Donald B.. Rubin , edition=. Statistical analysis with missing data , year =

  58. [66]

    Flexible Imputation of Missing Data, Second Edition , url =

    Stef van Buuren , city =. Flexible Imputation of Missing Data, Second Edition , url =. doi:10.1201/9780429492259 , isbn =

    doi

  59. [67]

    Drug Overdose Deaths in the United States, 2002-2022 , url =

    Merianne Spencer and Matthew Garnett and Arialdi Miniño , city =. Drug Overdose Deaths in the United States, 2002-2022 , url =. doi:10.15620/cdc:135849 , institution =

    2002 doi

  60. [68]

    Schieber and Gery P

    Lyna Z. Schieber and Gery P. Guy and Puja Seth and Randall Young and Christine L. Mattson and Christina A. Mikosz and Richard A. Schieber , doi =. Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017 , volume =. JAMA Ne...

    2006

  61. [69]

    Mejia and Srekar N

    Tarek Ghaddar and Allison Ferris and Maria C. Mejia and Srekar N. Ravi and Robert S. Levine and Charles H. Hennekens and Jennifer W. Caceres , doi =. Evolving Trends in US Mortality from Opioid Overdose: Heroin and Beyond , volume =. The American Journal of Medicine , keywords =

  62. [70]

    Jones and Shashim A

    Abenaa A. Jones and Shashim A. Waghmare and Joel E. Segel and Eric D. Harrison and Hannah B. Apsley and Alexis R. Santos‐Lozada , doi =. Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–2021 , url =. The American J...

    2012

  63. [71]

    Donnelly , doi =

    Rachel Laing and Christl A. Donnelly , doi =. Evolution of an epidemic: Understanding the opioid epidemic in the United States and the impact of the COVID-19 pandemic on opioid-related mortality , volume =. PLOS ONE , month =

  64. [72]

    Polysubstance mortality trends in White and Black Americans during the opioid epidemic, 1999–2018 , volume =

    Marwa Rawy and Gergis Abdalla and Kevin Look , doi =. Polysubstance mortality trends in White and Black Americans during the opioid epidemic, 1999–2018 , volume =. BMC Public Health , keywords =

    1999

  65. [73]

    Brinzo and Silvia S

    Paige N. Brinzo and Silvia S. Martins , doi =. Racial/ethnic trends in opioid and polysubstance opioid overdose mortality in adolescents and young adults, 1999–2020 , volume =. Addictive Behaviors , keywords =

    1999

  66. [74]

    Impact of opioid overdoses on US life expectancy and years of life lost, by demographic group and stimulant co-involvement: a mortality data analysis from 2019-2022 , volume =

    Anne H Hébert and Alison L Hill , doi =. Impact of opioid overdoses on US life expectancy and years of life lost, by demographic group and stimulant co-involvement: a mortality data analysis from 2019-2022 , volume =. The Lancet Regional Health - Americas , pages =

    2019

  67. [75]

    Using Precision Epidemiology to Identify Racialized Disparities in Overdose Mortality , url =

    Amir Forati and Rina Ghose and John Mantsch , doi =. Using Precision Epidemiology to Identify Racialized Disparities in Overdose Mortality , url =

  68. [76]

    Understanding the spatiotemporal evolution of opioid overdose events using a regionalized sequence alignment analysis

    Yuchen Li and Harvey J Miller and Ayaz Hyder and Peng Jia , doi =. Understanding the spatiotemporal evolution of opioid overdose events using a regionalized sequence alignment analysis. , volume =. Social science & medicine (1982) , keywords =

    1982

  69. [77]

    Knuth: Computers and Typesetting

    Donald Knuth. Knuth: Computers and Typesetting

  70. [78]

    Intrinsic Gaussian Markov random fields , year =

    Havard Rue and Leonhard Held , city =. Intrinsic Gaussian Markov random fields , year =. Gaussian Markov Random Fields Theory and Applications , month =

  71. [79]

    A class of models for large zero-inflated spatial data , year =

    Ben Seiyon Lee and Murali Haran , doi =. A class of models for large zero-inflated spatial data , year =. Journal of Agricultural, Biological and Environmental Statistics , keywords =

  72. [80]

    2024 , note =

    loo: Efficient leave-one-out cross-validation and WAIC for Bayesian models , author =. 2024 , note =

    2024

  73. [81]

    Rao Chaganty , doi =

    Monika Arora and N. Rao Chaganty , doi =. Application of Mixture Models for Doubly Inflated Count Data , volume =. Analytics , month =

  74. [82]

    A framework of zero-inflated Bayesian negative binomial regression models for spatiotemporal data , volume =

    Qing He and Hsin-Hsiung Huang , doi =. A framework of zero-inflated Bayesian negative binomial regression models for spatiotemporal data , volume =. Journal of Statistical Planning and Inference , keywords =

  75. [83]

    Macdonald and George Tzougas and George Streftaris , doi =

    Alex Jose and Angus S. Macdonald and George Tzougas and George Streftaris , doi =. Interpretable zero-inflated neural network models for predicting admission counts , year =. Annals of Actuarial Science , keywords =

  76. [84]

    Axalan and M

    A. Axalan and M. Ghahramani and D. Slonowsky , doi =. Time series regression models for zero-inflated proportions , volume =. Journal of Statistical Computation and Simulation , keywords =

  77. [85]

    Journal of Computational and Graphical Statistics , volume=

    Bayesian change point detection with spike-and-slab priors , author=. Journal of Computational and Graphical Statistics , volume=. 2023 , publisher=

    2023

  78. [86]

    The Annals of Applied Statistics , volume=

    Multiple imputation of hierarchical nonlinear time series data with an application to school enrollment data , author=. The Annals of Applied Statistics , volume=. 2025 , publisher=

    2025

  79. [87]

    Journal of Computational and Graphical Statistics , volume=

    Change-point detection for graphical models in the presence of missing values , author=. Journal of Computational and Graphical Statistics , volume=. 2021 , publisher=

    2021

  80. [88]

    The annals of applied statistics , volume=

    Biomarker change-point estimation with right censoring in longitudinal studies , author=. The annals of applied statistics , volume=

  81. [89]

    Journal of Computational and Graphical Statistics , volume=

    Spatially Clustered Compositional Regression: A Nonparametric Bayesian Approach , author=. Journal of Computational and Graphical Statistics , volume=. 2026 , publisher=

    2026

  82. [90]

    Journal of the American Statistical Association , volume=

    Mixture models with a prior on the number of components , author=. Journal of the American Statistical Association , volume=. 2018 , publisher=

    2018

  83. [91]

    Science , volume=

    Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016 , author=. Science , volume=. 2018 , publisher=

    1979

  84. [92]

    US Census Bureau , year=

    Data synthesis and perturbation for the American Community Survey at the US Census Bureau , author=. US Census Bureau , year=

  85. [93]

    Journal of Computational and Graphical Statistics , volume=

    Programming with models: writing statistical algorithms for general model structures with NIMBLE , author=. Journal of Computational and Graphical Statistics , volume=. 2017 , publisher=

    2017

  86. [94]

    Journal of Substance Abuse Treatment , volume=

    Characterizing variability in state-level regulations governing opioid treatment programs , author=. Journal of Substance Abuse Treatment , volume=. 2020 , publisher=

    2020

  87. [95]

    Journal of computational and graphical statistics , volume=

    Markov chain sampling methods for Dirichlet process mixture models , author=. Journal of computational and graphical statistics , volume=. 2000 , publisher=

    2000

  88. [96]

    Journal of Open Source Software , volume=

    nimbleHMC: An R package for Hamiltonian Monte Carlo sampling in nimble , author=. Journal of Open Source Software , volume=

  89. [97]

    , author=

    The No-U-Turn sampler: adaptively setting path lengths in Hamiltonian Monte Carlo. , author=. J. Mach. Learn. Res. , volume=

  90. [98]

    Proceedings of the 24th ACM SIGKDD international conference on knowledge discovery & data mining , pages=

    The US Census Bureau adopts differential privacy , author=. Proceedings of the 24th ACM SIGKDD international conference on knowledge discovery & data mining , pages=

  91. [99]

    Science Advances , volume=

    Impacts of census differential privacy for small-area disease mapping to monitor health inequities , author=. Science Advances , volume=. 2023 , publisher=

    2023

  92. [100]

    Health Services and Outcomes Research Methodology , volume=

    Privacy protection and aggregate health data: a review of tabular cell suppression methods (not) employed in public health data systems , author=. Health Services and Outcomes Research Methodology , volume=. 2016 , publisher=

    2016

  93. [101]

    JAMA Network Open , volume=

    Decline in US drug overdose deaths by region, substance, and demographics , author=. JAMA Network Open , volume=

  94. [102]

    International Journal of Drug Policy , volume=

    US overdose mortality saw first drop below the Jalal-Burke exponential growth curve in 2024 , author=. International Journal of Drug Policy , volume=. 2026 , publisher=

    2024

  95. [103]

    Disclosure Avoidance for Statistical Products , year =

  96. [104]

    Canadian Journal of Statistics , volume=

    Censored time series analysis with autoregressive moving average models , author=. Canadian Journal of Statistics , volume=. 2007 , publisher=

    2007

  97. [105]

    Proceedings of the survey research methods section of the American Statistical Association , volume=

    Multiple imputations in sample surveys-a phenomenological Bayesian approach to nonresponse , author=. Proceedings of the survey research methods section of the American Statistical Association , volume=. 1978 , organization=

    1978

  98. [106]

    Multiple Imputation for Nonresponse in Surveys , publisher =

    Rubin, Donald , year=. Multiple Imputation for Nonresponse in Surveys , publisher =

  99. [107]

    Statistical Science , volume=

    Multiple Imputation: A Review of Practical and Theoretical Findings , author=. Statistical Science , volume=

  100. [108]

    Currently under review , volume=

    Exploring an adaptive Metropolis algorithm , author=. Currently under review , volume=. 2010 , publisher=

    2010

  101. [109]

    The Journal of Machine Learning Research , volume=

    A widely applicable Bayesian information criterion , author=. The Journal of Machine Learning Research , volume=. 2013 , publisher=

    2013

  102. [110]

    International Journal of Drug Policy , volume=

    The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis , author=. International Journal of Drug Policy , volume=. 2019 , publisher=

    2019

  103. [111]

    JAMA network open , volume=

    Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007-2018 , author=. JAMA network open , volume=

    2007

  104. [112]

    Anesthesia & Analgesia , volume=

    The US opioid crisis: current federal and state legal issues , author=. Anesthesia & Analgesia , volume=

  105. [113]

    Proceedings of the National Academy of Sciences , volume=

    Modeling the evolution of the US opioid crisis for national policy development , author=. Proceedings of the National Academy of Sciences , volume=. 2022 , publisher=

    2022

  106. [114]

    International Journal of Maternal and Child Health and AIDS , volume=

    Opioid epidemic in the United States: empirical trends, and a literature review of social determinants and epidemiological, pain management, and treatment patterns , author=. International Journal of Maternal and Child Health and AIDS , volume=

  107. [115]

    Biostatistics , volume=

    A Bayesian mixture modeling approach for public health surveillance , author=. Biostatistics , volume=. 2020 , publisher=

    2020

  108. [116]

    Journal of the Royal Statistical Society Series C: Applied Statistics , volume=

    Bayesian spatio-temporal small area modelling: a case study investigating the late-stage melanoma incidence in Texas , author=. Journal of the Royal Statistical Society Series C: Applied Statistics , volume=. 2026 , publisher=

    2026

  109. [117]

    Foundations and trends in econometrics , volume=

    Bayesian multivariate time series methods for empirical macroeconomics , author=. Foundations and trends in econometrics , volume=. 2010 , publisher=

    2010

  110. [118]

    Journal of Economic perspectives , volume=

    Vector autoregressions , author=. Journal of Economic perspectives , volume=. 2001 , publisher=

    2001

  111. [119]

    2011 , publisher=

    Statistics for spatio-temporal data , author=. 2011 , publisher=

    2011

  112. [120]

    2013 , publisher=

    Statistical analysis of spatial and spatio-temporal point patterns , author=. 2013 , publisher=

    2013

  113. [121]

    Biostatistics , volume=

    A Bayesian forecasting model: predicting US male mortality , author=. Biostatistics , volume=. 2006 , publisher=

    2006

  114. [122]

    Statistics in medicine , volume=

    Multivariate modelling of infectious disease surveillance data , author=. Statistics in medicine , volume=. 2008 , publisher=

    2008

  115. [123]

    Annual Review of Statistics and its Application , volume=

    Infectious disease modeling , author=. Annual Review of Statistics and its Application , volume=. 2025 , publisher=

    2025

  116. [124]

    Statistical modelling , volume=

    A statistical framework for the analysis of multivariate infectious disease surveillance counts , author=. Statistical modelling , volume=. 2005 , publisher=

    2005

  117. [125]

    Statistica Sinica , pages=

    Clustering curves based on change point analysis: a nonparametric Bayesian approach , author=. Statistica Sinica , pages=. 2015 , publisher=

    2015

  118. [126]

    Journal of the Royal Statistical Society Series B: Statistical Methodology , pages=

    ART: distribution-free and model-agnostic changepoint detection with finite-sample guarantees , author=. Journal of the Royal Statistical Society Series B: Statistical Methodology , pages=. 2026 , publisher=

    2026

  119. [127]

    Statistical Science , pages=

    Multiple change-point detection: a selective overview , author=. Statistical Science , pages=. 2016 , publisher=

    2016

  120. [128]

    Annual Review of Statistics and Its Application , volume=

    Change-Point Detection and Its Modern Applications , author=. Annual Review of Statistics and Its Application , volume=. 2025 , publisher=

    2025

  121. [129]

    Technometrics , volume=

    Bayesian hierarchical model for change point detection in multivariate sequences , author=. Technometrics , volume=. 2022 , publisher=

    2022

  122. [130]

    The annals of applied statistics , volume=

    A multivariate spatiotemporal change-point model of opioid overdose deaths in Ohio , author=. The annals of applied statistics , volume=. 2021 , publisher=

    2021

  123. [131]

    Knowledge and information systems , volume=

    A survey of methods for time series change point detection , author=. Knowledge and information systems , volume=. 2017 , publisher=

    2017

  124. [132]

    Statistics in medicine , volume=

    Permutation tests for joinpoint regression with applications to cancer rates , author=. Statistics in medicine , volume=. 2000 , publisher=

    2000

  125. [133]

    The Annals of Mathematical Statistics , volume=

    Estimating the current mean of a normal distribution which is subjected to changes in time , author=. The Annals of Mathematical Statistics , volume=. 1964 , publisher=

    1964

  126. [134]

    Journal of econometrics , volume=

    Estimation and comparison of multiple change-point models , author=. Journal of econometrics , volume=. 1998 , publisher=

    1998

  127. [135]

    The Review of Economic Studies , volume=

    Estimation and forecasting in models with multiple breaks , author=. The Review of Economic Studies , volume=. 2007 , publisher=

    2007

  128. [136]

    Bayesian Analysis , volume=

    Dirichlet Process Hidden Markov Multiple Change-point Model , author=. Bayesian Analysis , volume=

  129. [137]

    Econometrica , volume=

    Estimating and testing structural changes in multivariate regressions , author=. Econometrica , volume=. 2007 , publisher=

    2007

  130. [138]

    Biometrika , volume=

    Detecting simultaneous changepoints in multiple sequences , author=. Biometrika , volume=. 2010 , publisher=

    2010

  131. [139]

    THE ANNALS of APPLIED STATISTICS , pages=

    EMPIRICAL BAYESIAN ANALYSIS OF SIMULTANEOUS CHANGEPOINTS IN MULTIPLE DATA SEQUENCES , author=. THE ANNALS of APPLIED STATISTICS , pages=. 2017 , publisher=

    2017

  132. [140]

    Drug Overdose Deaths in the United States, 2023--2024 , author=

    2023

  133. [141]

    Journal of time series analysis , volume=

    Integer-valued GARCH process , author=. Journal of time series analysis , volume=. 2006 , publisher=

    2006

  134. [142]

    American Journal of Preventive Medicine , volume=

    Trends in Fatal Opioid-Related Overdose in American Indian and Alaska Native Communities, 1999--2021 , author=. American Journal of Preventive Medicine , volume=. 2024 , publisher=

    1999

  135. [143]

    , author=

    Dirichlet process. , author=. Encyclopedia of machine learning , volume=

  136. [144]

    Bayesian inference for gene expression and proteomics , volume=

    Model-based clustering for expression data via a Dirichlet process mixture model , author=. Bayesian inference for gene expression and proteomics , volume=

  137. [145]

    Journal of the American Statistical Association , volume=

    Estimation and variable selection for interval-censored failure time data with random change point and application to breast cancer study , author=. Journal of the American Statistical Association , volume=. 2025 , publisher=

    2025

  138. [146]

    Addiction , year=

    Charting the decline of the fourth wave: US overdose deaths by race, ethnicity and substance involvement , author=. Addiction , year=

  139. [147]

    Physical Chemistry Chemical Physics , volume=

    Parallel tempering: Theory, applications, and new perspectives , author=. Physical Chemistry Chemical Physics , volume=. 2005 , publisher=

    2005

Pith tools

Reviewed August 11, 2026 · model on record in the stance chip above.